Literature DB >> 8739399

Correlations between mental state and quantitative neuropathology in the Vienna Longitudinal Study on Dementia.

C Bancher1, K Jellinger, H Lassmann, P Fischer, F Leblhuber.   

Abstract

Quantitative clinicopathological correlation studies are one way to address the question of the relevance of morphological abnormalities in Alzheimer's dementia (AD). This paper summarizes results of the Vienna Longitudinal Study on Dementia obtained during the past few years and presents a critical discussion on the relevance of clinicopathological correlation studies for the pathogenesis of AD. Plotting of psychometric test scores against the numbers of plaques, tangles and neuropil threads in various cortical areas shows that significant correlations are due primarily to very high lesion counts in severely demented patients. These data indicate that neocortical neurofibrillary pathology can be considered an end-stage marker in the pathology of AD. On the other hand, the topographical staging of neuritic Alzheimer changes proposed by Braak and Braak (1991) appears to be a better reflection of the progression of the degenerative process than numerical lesion counts; there is a linear correlation between the Braak stages and Mini-Mental State scores in 122 aged individuals. Significant correlations are further obtained between the severity of dementia and the levels of a number of synaptic proteins including synaptophysin and the chromogranins. Taken together, our data suggest that none of the classical AD lesions, plaques and tangles, play a central role in the pathogenesis of dementia, a fact that is supported by a molecular biological study showing that there is no close relationship between these lesions and the neurons undergoing degeneration in AD. Whereas neuritic pathology is a useful histopathological marker for the diagnosis and staging of AD, the major correlate of cognitive deficits is the loss of corticocortical and subcorticocortical connections reflected by a depletion of synapses. This pathology may be induced by a mismetabolism of the beta-amyloid precursor proteins or their interaction with cytoskeletal proteins related to neuronal degeneration.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8739399     DOI: 10.1007/bf02189115

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  66 in total

1.  Synaptic pathology in Alzheimer's disease: immunological data for markers of synaptic and large dense-core vesicles.

Authors:  H Lassmann; R Weiler; P Fischer; C Bancher; K Jellinger; E Floor; W Danielczyk; F Seitelberger; H Winkler
Journal:  Neuroscience       Date:  1992       Impact factor: 3.590

2.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

3.  Evaluating storage, retention, and retrieval in disordered memory and learning.

Authors:  H Buschke; P A Fuld
Journal:  Neurology       Date:  1974-11       Impact factor: 9.910

4.  The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

Authors:  G Blessed; B E Tomlinson; M Roth
Journal:  Br J Psychiatry       Date:  1968-07       Impact factor: 9.319

5.  The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases.

Authors:  M C Tierney; R H Fisher; A J Lewis; M L Zorzitto; W G Snow; D W Reid; P Nieuwstraten
Journal:  Neurology       Date:  1988-03       Impact factor: 9.910

6.  Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid beta-protein precursor.

Authors:  C Haass; A Y Hung; D J Selkoe; D B Teplow
Journal:  J Biol Chem       Date:  1994-07-01       Impact factor: 5.157

7.  About the presence of paired helical filaments in dystrophic neurites participating in the plaque formation.

Authors:  M Barcikowska; H M Wisniewski; C Bancher; I Grundke-Iqbal
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

8.  Clinicopathologic correlates in Alzheimer disease: assessment of clinical and pathologic diagnostic criteria.

Authors:  A M Kazee; T A Eskin; L W Lapham; K R Gabriel; K D McDaniel; R W Hamill
Journal:  Alzheimer Dis Assoc Disord       Date:  1993       Impact factor: 2.703

9.  Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease.

Authors:  L M Bierer; P R Hof; D P Purohit; L Carlin; J Schmeidler; K L Davis; D P Perl
Journal:  Arch Neurol       Date:  1995-01

10.  The topography of plaques and tangles in Down's syndrome patients of different ages.

Authors:  D M Mann; P O Yates; B Marcyniuk; C R Ravindra
Journal:  Neuropathol Appl Neurobiol       Date:  1986 Sep-Oct       Impact factor: 8.090

View more
  29 in total

1.  Entorhinal verrucae geometry is coincident and correlates with Alzheimer's lesions: a combined neuropathology and high-resolution ex vivo MRI analysis.

Authors:  Jean C Augustinack; Kristen E Huber; Gheorghe M Postelnicu; Sita Kakunoori; Ruopeng Wang; André J W van der Kouwe; Lawrence L Wald; Thor D Stein; Matthew P Frosch; Bruce Fischl
Journal:  Acta Neuropathol       Date:  2011-12-13       Impact factor: 17.088

2.  Alzheimer disease pathology in subjects without dementia in 2 studies of aging: the Nun Study and the Adult Changes in Thought Study.

Authors:  Karen S SantaCruz; Joshua A Sonnen; Maryam Kherad Pezhouh; Mark F Desrosiers; Peter T Nelson; Suzanne L Tyas
Journal:  J Neuropathol Exp Neurol       Date:  2011-10       Impact factor: 3.685

3.  Clinical dementia rating performed several years prior to death predicts regional Alzheimer's neuropathology.

Authors:  Michal Schnaider Beeri; Jeremy M Silverman; James Schmeidler; Michael Wysocki; Hillel Z Grossman; Dushyant P Purohit; Daniel P Perl; Vahram Haroutunian
Journal:  Dement Geriatr Cogn Disord       Date:  2008-03-27       Impact factor: 2.959

4.  Digital pathology and image analysis for robust high-throughput quantitative assessment of Alzheimer disease neuropathologic changes.

Authors:  Janna Hackett Neltner; Erin Lynn Abner; Frederick A Schmitt; Stephanie Kay Denison; Sonya Anderson; Ela Patel; Peter T Nelson
Journal:  J Neuropathol Exp Neurol       Date:  2012-12       Impact factor: 3.685

Review 5.  Small-molecule PET Tracers for Imaging Proteinopathies.

Authors:  Chester A Mathis; Brian J Lopresti; Milos D Ikonomovic; William E Klunk
Journal:  Semin Nucl Med       Date:  2017-07-13       Impact factor: 4.446

6.  Curcumin/melatonin hybrid 5-(4-hydroxy-phenyl)-3-oxo-pentanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide ameliorates AD-like pathology in the APP/PS1 mouse model.

Authors:  Gorka Gerenu; Kai Liu; Jeremy E Chojnacki; John M Saathoff; Pablo Martínez-Martín; George Perry; Xiongwei Zhu; Hyoung-Gon Lee; Shijun Zhang
Journal:  ACS Chem Neurosci       Date:  2015-05-04       Impact factor: 4.418

7.  Monoclonal antibodies to a 100-kd protein reveal abundant A beta-negative plaques throughout gray matter of Alzheimer's disease brains.

Authors:  M L Schmidt; V M Lee; M Forman; T S Chiu; J Q Trojanowski
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

8.  Psychosis in "Cognitively Asymptomatic" Elderly Subjects is Associated With Neuritic Plaque Load, Not Neurofibrillary Tangles.

Authors:  Julia Kim; Tom A Schweizer; Corinne E Fischer; David G Munoz
Journal:  Alzheimer Dis Assoc Disord       Date:  2018 Jul-Sep       Impact factor: 2.703

9.  Applicability of digital analysis and imaging technology in neuropathology assessment.

Authors:  William D Dunn; Marla Gearing; Yuna Park; Lifan Zhang; John Hanfelt; Jonathan D Glass; David A Gutman
Journal:  Neuropathology       Date:  2015-11-18       Impact factor: 1.906

Review 10.  Molecular and cellular pathophysiology of preclinical Alzheimer's disease.

Authors:  Elliott J Mufson; Milos D Ikonomovic; Scott E Counts; Sylvia E Perez; Michael Malek-Ahmadi; Stephen W Scheff; Stephen D Ginsberg
Journal:  Behav Brain Res       Date:  2016-05-13       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.